Iain M. Cockburn is Professor of Finance and Economics and Everett W. Lord Distinguished Faculty Scholar in the School of Management at Boston University, where he teaches and performs research in the areas of business strategy, intellectual property, economics of innovation, and management of high technology companies. As the ITEC Director, Research Programs, Dr. Cockburn oversees all ITEC research initiatives and serves as academic faculty liaison with entrepreneurship activities across the Boston University campus.
Dr. Rosen developed advanced medical technologies for cardiovascular, neurosurgical, and spinal surgery prior to becoming the executive director of ITEC. He served as Chief Technology Officer for the Codman & Surtleff Surgical Division of Johnson & Johnson. His entrepreneurial experience includes the founding of medical technology companies in the US and internationally. He served as director of the CIMIT Office of Technology Implementation, where he helped establish collaborative research teams and support translational research programs in biomaterials, tissue engineering, optical diagnostics, orthopedics, trauma and critical care. He continues to serve as senior advisor to CIMIT, is the principal investigator for the CIMIT global health program, and is a founding board member of the Institute for Pediatric Innovation. Jonathan received his PhD in Biomaterials and Bioengineering from Case Western Reserve University and his MBA in Strategic Planning from Columbia University.
Ashley J. Stevens is the Executive Director, Office of Technology Transfer, at Boston University. As an ITEC Senior Research Associate and Lecturer, Dr. Stevens teaches on the research commercialization process, and his research focuses on intellectual property creation and management. Dr. Stevens has been Director of the Office of Technology Transfer since 1995. Since he joined Boston University, the Office of Technology Transfer has spun out over 40 companies based on the University’s research. Before joining Boston University, he was Director of the Office of Technology Transfer at the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School. Prior to entering the technology transfer provision, Ashley worked in the biotechnology industry and founded several companies including Kytogenics, Inc and Genmap, Inc. He started his career with the Procter & Gamble Company and holds a BA in Natural Sciences and an MA PhD in Physical Chemistry from Oxford University.